Pages

▼
Tuesday, March 03, 2026

Preorder Now: DCI’s 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

›
On March 24, 2026, Drug Channels Institute will release The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers . This re...
Friday, February 27, 2026

Beyond DTP 2.0: How Flexible Direct-to-Patient Programs Power Best-In-Class Patient Experiences

›
Today’s guest post comes from Allison Bridges, SVP Client Success at PHIL Inc. and Cindy Eckert, Founder and CEO of Sprout Pharmaceuticals...
Tuesday, February 24, 2026

Drug Channels News Roundup, February 2026: Mark Cuban on FTC-ESI, What Patients Really Want, QALYs vs. MFN, 340B’s Site of Care Shift, and New Faces at DCI

›
Despite the recent storm, winter—or at least February—is almost over. Before we thaw out, here’s a brisk tour of the forces reshaping the dr...
Friday, February 20, 2026

The State of Patient Access: What Industry Leaders Reveal in a New Survey About Hub Models, Technology, and the Road Ahead

›
Today’s guest post comes from Scott Genone, Chief Product Officer at CareMetx. Scott shares findings from CareMetx’s 2026 Patient Service...
Wednesday, February 18, 2026

Medicare Part D Pharmacy Networks in 2026: Supermarkets Dominate as Drugstores Stall and Independents Walk Away

›
The Centers for Medicare & Medicaid Services (CMS) has just released its initial 2026 data on enrollment in Medicare Part D prescription...
Friday, February 13, 2026

The Key to a Better Patient Experience: Improved GTN

›
Today’s guest post comes from Gerard Rivera, CEO and Co-Founder of RIS Rx. Gerard reframes patient affordability as a clinical issue rath...
Tuesday, February 10, 2026

Copay Accumulators and Maximizers in 2025: Popular, Profitable, and Problematic

›
Valentine’s Day is almost here! It’s the perfect time for our annual update on plan sponsors’ enduring sweetheart: copay accumulators and ma...
Friday, February 06, 2026

In an Uncertain 340B Environment, Kalderos Offers a Clear Path Forward

›
Today’s guest post comes from Angie Franks, Chief Executive Officer at Kalderos. Angie examines the growing uncertainty surrounding the 3...
Wednesday, February 04, 2026

The FTC Blows Up Express Scripts’ PBM Model—and Launches the Net Pricing Drug Channel

›
Earlier today, the Federal Trade Commission (FTC) announced an extraordinary settlement with Express Scripts that fundamentally reshapes its...
Tuesday, February 03, 2026

Latest CMS Data Reveal Six Trends Reshaping U.S. Drug Spending

›
The boffins at the Centers for Medicare & Medicaid Services (CMS) recently dropped the latest National Health Expenditure (NHE) data, wh...
Friday, January 30, 2026

From Cost Center to Insights Center: How Patient Support Will Go Beyond the Call in 2026

›
Today’s guest post comes from Brok Vandersteen, Vice President of Business Development at AssistRx. Brok argues that in 2026, traditional...
Tuesday, January 27, 2026

Drug Channels News Roundup, January 2026: Cuban vs. Optum, McKesson’s Biosimilar Play, States vs. Accumulators, 340B Windfalls, and Ozempic Ads

›
Super Bowl LX is almost here! Time for some blowout beer and snack commercials, occasionally interrupted by an actual football game. DCI’s h...